FTC Asks 1st Circ. To Reverse Momenta Antitrust Win

Law360, Fort Wayne (November 8, 2016, 2:29 PM EST) -- The Federal Trade Commission on Monday told the First Circuit that a lower court had incorrectly granted immunity to Momenta Pharmaceuticals Inc. from an antitrust suit by Amphastar Pharmaceuticals Inc. and asked the appeals court to reverse that decision.

In his July ruling dismissing the action, U.S. District Judge Nathaniel M. Gorton erroneously applied the Noerr-Pennington doctrine, which states that petitioning the government for redress is generally exempt from antitrust liability, the FTC said. Judge Gorton did not identify any such actions by Momenta before the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.